FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286221646> ?p ?o ?g. }

• W4286221646 endingPage "398" @default.
• W4286221646 startingPage "390" @default.
• W4286221646 abstract "Background Multiparametric MRI has led to increased detection of clinically significant prostate cancer (csPCa). Micro-US is being investigated for csPCa detection. Purpose To compare multiparametric MRI and micro-US in detecting csPCa (grade group ≥2) and to determine the proportion of MRI nodules visible at micro-US for real-time targeted biopsy. Materials and methods This prospective, single-center trial enrolled biopsy-naive men with suspected prostate cancer (PCa) between May 2019 and September 2020. All patients underwent multiparametric MRI followed by micro-US; findings at both were interpreted in a blinded fashion, followed by targeted biopsy and nontargeted systematic biopsy using micro-US. Proportions were compared using the exact McNemar test. The differences in proportions were calculated. Results Ninety-four men (median age, 61 years; IQR, 57-68 years) were included. MRI- and micro-US-targeted biopsy depicted csPCa in 37 (39%) and 33 (35%) of the 94 men, respectively (P = .22); clinically insignificant PCa in 14 (15%) and 15 (16%) (P > .99); and cribriform and/or intraductal PCa in 14 (15%) and 13 (14%) (P > .99). The MRI- plus micro-US-targeted biopsy pathway depicted csPCa in 38 of the 94 (40%) men. The addition of nontargeted systematic biopsy to MRI- plus micro-US-targeted biopsy did not enable identification of any additional men with csPCa but did help identify nine additional men with clinically insignificant PCa (P = .04). Biopsy was avoided in 32 of the 94 men (34%) with MRI and nine of the 94 men (10%) with micro-US (P < .001). Among 93 MRI targets, 62 (67%) were prospectively visible at micro-US. Conclusion MRI and micro-US showed similar rates of prostate cancer detection, but more biopsies were avoided with the MRI pathway than with micro-US, with no benefit of adding nontargeted systematic biopsy to the MRI- plus micro-US-targeted biopsy pathway. Most MRI lesions were prospectively visible at micro-US, allowing real-time targeted biopsy. ClinicalTrials.gov registration no.: NCT03938376 © RSNA, 2022 Online supplemental material is available for this article." @default.
• W4286221646 created "2022-07-21" @default.
• W4286221646 creator A5012397578 @default.
• W4286221646 creator A5014191976 @default.
• W4286221646 creator A5021475018 @default.
• W4286221646 creator A5022494685 @default.
• W4286221646 creator A5027990022 @default.
• W4286221646 creator A5038617581 @default.
• W4286221646 creator A5045685892 @default.
• W4286221646 creator A5073049265 @default.
• W4286221646 creator A5074359131 @default.
• W4286221646 creator A5077530775 @default.
• W4286221646 creator A5081598999 @default.
• W4286221646 creator A5086086605 @default.
• W4286221646 creator A5088388062 @default.
• W4286221646 date "2022-11-01" @default.
• W4286221646 modified "2023-10-16" @default.
• W4286221646 title "Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men" @default.
• W4286221646 cites W2023418248 @default.
• W4286221646 cites W2029679802 @default.
• W4286221646 cites W2054808460 @default.
• W4286221646 cites W2058465496 @default.
• W4286221646 cites W2059653060 @default.
• W4286221646 cites W2111486311 @default.
• W4286221646 cites W2146694631 @default.
• W4286221646 cites W2253068469 @default.
• W4286221646 cites W2342803437 @default.
• W4286221646 cites W2577453388 @default.
• W4286221646 cites W2734348020 @default.
• W4286221646 cites W2768375169 @default.
• W4286221646 cites W2787761586 @default.
• W4286221646 cites W2793905111 @default.
• W4286221646 cites W2885908261 @default.
• W4286221646 cites W2892096175 @default.
• W4286221646 cites W2898522880 @default.
• W4286221646 cites W2900548778 @default.
• W4286221646 cites W2901859788 @default.
• W4286221646 cites W2922071185 @default.
• W4286221646 cites W2923048779 @default.
• W4286221646 cites W2991473497 @default.
• W4286221646 cites W2995898362 @default.
• W4286221646 cites W3016919090 @default.
• W4286221646 cites W3022544115 @default.
• W4286221646 cites W3041789325 @default.
• W4286221646 cites W3091100709 @default.
• W4286221646 cites W3102603150 @default.
• W4286221646 cites W3110412635 @default.
• W4286221646 cites W3128562958 @default.
• W4286221646 cites W3128653918 @default.
• W4286221646 cites W90255182 @default.
• W4286221646 doi "https://doi.org/10.1148/radiol.212163" @default.
• W4286221646 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35852425" @default.
• W4286221646 hasPublicationYear "2022" @default.
• W4286221646 type Work @default.
• W4286221646 citedByCount "10" @default.
• W4286221646 countsByYear W42862216462022 @default.
• W4286221646 countsByYear W42862216462023 @default.
• W4286221646 crossrefType "journal-article" @default.
• W4286221646 hasAuthorship W4286221646A5012397578 @default.
• W4286221646 hasAuthorship W4286221646A5014191976 @default.
• W4286221646 hasAuthorship W4286221646A5021475018 @default.
• W4286221646 hasAuthorship W4286221646A5022494685 @default.
• W4286221646 hasAuthorship W4286221646A5027990022 @default.
• W4286221646 hasAuthorship W4286221646A5038617581 @default.
• W4286221646 hasAuthorship W4286221646A5045685892 @default.
• W4286221646 hasAuthorship W4286221646A5073049265 @default.
• W4286221646 hasAuthorship W4286221646A5074359131 @default.
• W4286221646 hasAuthorship W4286221646A5077530775 @default.
• W4286221646 hasAuthorship W4286221646A5081598999 @default.
• W4286221646 hasAuthorship W4286221646A5086086605 @default.
• W4286221646 hasAuthorship W4286221646A5088388062 @default.
• W4286221646 hasConcept C105795698 @default.
• W4286221646 hasConcept C121608353 @default.
• W4286221646 hasConcept C126322002 @default.
• W4286221646 hasConcept C126838900 @default.
• W4286221646 hasConcept C126894567 @default.
• W4286221646 hasConcept C141071460 @default.
• W4286221646 hasConcept C186282968 @default.
• W4286221646 hasConcept C188816634 @default.
• W4286221646 hasConcept C2775934546 @default.
• W4286221646 hasConcept C2776235491 @default.
• W4286221646 hasConcept C2780192828 @default.
• W4286221646 hasConcept C2781217009 @default.
• W4286221646 hasConcept C2910607126 @default.
• W4286221646 hasConcept C2985322473 @default.
• W4286221646 hasConcept C33923547 @default.
• W4286221646 hasConcept C71924100 @default.
• W4286221646 hasConceptScore W4286221646C105795698 @default.
• W4286221646 hasConceptScore W4286221646C121608353 @default.
• W4286221646 hasConceptScore W4286221646C126322002 @default.
• W4286221646 hasConceptScore W4286221646C126838900 @default.
• W4286221646 hasConceptScore W4286221646C126894567 @default.
• W4286221646 hasConceptScore W4286221646C141071460 @default.
• W4286221646 hasConceptScore W4286221646C186282968 @default.
• W4286221646 hasConceptScore W4286221646C188816634 @default.
• W4286221646 hasConceptScore W4286221646C2775934546 @default.
• W4286221646 hasConceptScore W4286221646C2776235491 @default.
• W4286221646 hasConceptScore W4286221646C2780192828 @default.

• next